The pooled HR for OS in patients with cervical cancer who received PD-1 inhibitors was 0.68 (95% CI: 0.59–0.79, p <.001; I2 = 0%, Cochran’s p =.84; Supplementary Figure 2A) (21, 22). This evidence concerns the gene PDCD1 and cervical cancer.